HERVolution Therapeutics Demonstrates Preclinical Proof-of-Concept for Insulin Sensitization Immune Therapy in Metabolic Disease and Announces Exclusive License Agreement with the University of Copenhagen
Preclinical studies in disease-relevant models demonstrate the ability of HERVolution's HERV-targeting platform to control weight gain, reverse type 2 diabetes,...
Benchmark Senior Living Selects Sunbound to Help Modernize Resident Billing and Payments